Сòòò½ÊÓƵ

Bessel A. van der Kolk, MD, is a clinician, researcher and teacher in the area of post-traumatic stress. His work integrates developmental, neurobiological, psychodynamic and interpersonal aspects of the impact of trauma and its treatment.

Dr. van der Kolk and his various collaborators have published extensively on the impact of trauma on development, such as dissociative problems, borderline personality and self-mutilation, cognitive development, memory, and the psychobiology of trauma. He has published over 150 peer-reviewed scientific articles on such diverse topics as neuroimaging, self-injury, memory, neurofeedback, Developmental Trauma, yoga, theater, and EMDR. 

He is founder of the Trauma Center in Brookline, Massachusetts and President of the Trauma Research Foundation, which promotes clinical, scientific, and educational projects. 

His 2014 #1 New York Times best seller, The Body Keeps the Score: Brain, Mind, and Body in the Treatment of Trauma, transforms our understanding of traumatic stress, revealing how it literally rearranges the brain’s wiring – specifically areas dedicated to pleasure, engagement, control, and trust. He shows how these areas can be reactivated through innovative treatments including neurofeedback, somatically based therapies, EMDR, psychodrama, play, yoga, and other therapies.

Dr. van der Kolk is the past president of the International Society for Traumatic Stress Studies, and professor of psychiatry at Boston University Medical School. He regularly teaches at conferences, universities, and hospitals around the world.

Speaker Disclosures:
Financial: Dr. Bessel van der Kolk is a professor at Boston University School of Medicine, the Director of the Trauma Center, and the National Complex Trauma Network. He receives royalties as a published author. Dr. van der Kolk receives a speaking honorarium, recording royalties, and book royalties from Сòòò½ÊÓƵ. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Bessel van der Kolk has no relevant non-financial relationships with ineligible organizations.

Dr. Arnsten is an international expert on the molecular regulation of higher cortical circuits, and a member of the National Academy of Medicine. She was the first to discover that acute, uncontrollable stress impairs prefrontal cortical function, rapidly switching the brain from a reflective to reflexive state. Arnsten received her BA in neuroscience from Brown University in 1976 (where she created the neuroscience major), and her PhD in neuroscience from UCSD in 1981. She did post-doctoral research with Dr. Susan Iversen at Cambridge University in the UK, and with Dr. Patricia Goldman-Rakic at Yale. Dr. Arnsten’s research examines the unique molecular regulation of the prefrontal cortical circuits that generate higher cognition and top-down control, and how these circuits are markedly impaired by stress and inflammation, conferring vulnerability in mental illness. Arnsten’s research has led to new treatments for cognitive disorders in humans, including the successful translation of guanfacine (Intuniv) for the treatment of ADHD and related prefrontal cortical disorders.

Speaker Disclosures:
Financial: Dr. Amy Arnsten has an employment relationship with Yale University. She receives a speaking honorarium from Сòòò½ÊÓƵ. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Amy Arnsten sits on the editorial board for Journal of Cognitive Neuroscience, Behavioral and Brain Functions, Biological Psychiatry, and Neurobiology of Stress.

Robin Carhart-Harris, PhD, is a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London. He coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years.

After being awarded an MA in Psychoanalysis at Brunel University, London, Carhart-Harris completed his PhD in psychopharmacology at the University of Bristol. In 2009, under the mentorship of Professor David Nutt, he relocated to Imperial College, London to continue his fMRI research with the classic psychedelic psilocybin. In conjunction with David Nutt, he built up a program of psychedelic research that includes fMR and MEG imaging with psilocybin, fMR imaging with MDMA, and plans for an MRC-sponsored clinical trial to assess the efficacy of psilocybin as a treatment for major depression.

Speaker Disclosures:
Financial: Robin Carhart-Harris has employment relationships with Carhart-Harris Lab and the University of California. He is a consultant with TRYP Therapeutics, the Otsuka group, Entheos Labs, MindState, Osmind, and Journey Collab. Robin Carhart- Harris received a grant from Wellcome Leap. He receives a speaking honorarium from Сòòò½ÊÓƵ. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Robin Carhart-Harris is a member of the Association for Psychological Science, the Neuropsychoanalysis Association, and the International Society for Research on Psychedelics.

Pat Ogden, PhD, (she/her), Is a pioneer in somatic psychology, the creator of the Sensorimotor Psychotherapy method, and founder of the Sensorimotor Psychotherapy Institute. Dr. Ogden is a clinician, consultant, international lecturer, and the first author of two groundbreaking books in somatic psychology: Trauma and the Body: A Sensorimotor Approach to Psychotherapy and Sensorimotor Psychotherapy: Interventions for Trauma and Attachment (2015). Her third book, The Pocket Guide to Sensorimotor Psychotherapy in Context, advocates for an anti-racist perspective in psychotherapy practice. Her current interests include couple therapy, child and family therapy, social justice, diversity, inclusion, consciousness, and the philosophical/spiritual principles that underlie her work.